Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pazopanib monotherapy after first-line chemotherapy in Asian women with ovarian, fallopian tube, or primary peritoneal cancer reports…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Ovarian | Phase 2 | Status: COMPLETED | Results posted: 2013-06-04